Sanofi is dedicated to supporting people through their health challenges. We are a global biopharmaceutical company focused on human health. We prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. We stand by the few who suffer from rare diseases and the millions with long-term chronic conditions. With more than 100,000 people in 100 countries, Sanofi is transforming scientific innovation into healthcare solutions around the globe.
AOP Orphan Pharmaceuticals AG is an international pharmaceutical company with a focus on rare and special diseases. Over the past 25 years, the company has become an established provider of integrated therapy solutions from its headquarters in Vienna. This has been made possible by a high level of investment in research and development and a strong orientation towards the needs of especially the patients and their families but also the doctors and health care professionals.
F4 Pharma, a clinical-stage biopharmaceutical company developing F06, an anti-inflammatory therapeutic that has shown to improve vascular integrity, FX06 is a substance discovered and developed in the Medical University of Vienna and has a dual mode of action: it is reducing the capillary leak and has anti-inflammatory efficacy. In Covid-19 by reducing pulmonary vascular hyperpermeability, FX06 is supposed to lead to improved lung function and reduced time of mechanical ventilation.
Bayer has core competencies in the fields of health care and nutrition. We address the challenges presented by a growing and aging global population and are committed to drive sustainable development, generate a positive impact with our businesses and create value through innovation and growth. Bayer Austria is a subsidiary of Bayer AG, based in Vienna, where about 190 employees are responsible for marketing, sales, medical information on Bayer-products and clinical studies.
GSK is a leading global research-driven healthcare company with approximately 94,000 employees in 96 countries. At GSK Austria, about 80 employees are working to make a wide range of prescription drugs and vaccines available to as many people as possible in Austria - focusing on transformative therapies in oncology, severe asthma and HIV. For the seventh year in a row, GSK is number one in the Access to Medicine Index and GSK Austria is a member of Transparency International Austria.
AstraZeneca Österreich GmbH is one of the leading pharmaceutical companies in Austria and develops, manufactures and markets innovative drugs for the treatment of diseases in the fields of cardiovascular and metabolism, oncology, respiratory diseases and for the treatment of infectious and autoimmune diseases.
Haplogen, founded 2010 is a Vienna based, privately owned biotechnology company. Based on a novel mechanism Haplogen develops proprietary small molecule therapeutic compounds for the treatment of diseases that lead to adipositas and obesity.
Valneva is a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. We have leveraged our expertise and capabilities both to successfully commercialize two vaccines and to rapidly advance a broad range of vaccine candidates into and through the clinic, including candidates against Lyme disease, the chikungunya virus and COVID-19.
Vienna Textile Lab fabricates organic colours made by naturally occurring bacteria in order to provide the most sustainable, wholesome and environmentally friendly alternative to conventional synthetic colours. Using Vienna Textile Lab colours to dye your textiles means to act responsible and thoughtful. We help designers use new type of materials, methods and concepts in the textile business. Vienna Textile Lab makes dyeing go easy on human and ecological resources.
Eveliqure Biotechnologies is an innovative biotech company developing novel vaccines for the prevention of diarrhoeal diseases both for travellers and people living in endemic regions of low- and middle-income countries.
We are a global healthcare company with a history of more than 125 years, dedicated to improving patients' lives. Our mission is to discover, develop and deliver products and services that help people and animals around the world live healthier lives.
Cutanos GmbH is a viennese biotech company founded in early 2021 focussing on preclinal development of antigen-specific vaccines and new treatments for autoimmune disorders. Cutanos uses a modular and highly flexible drug delivery system called the Langerhans Cell Targeted Delivery System (LC-TDS). With this technology, the company aims to realize innovative immunotherapies in conjunction with minimally invasive administration.
Established in 2007, Lexogen is a leading company in transcriptomics, next-generation sequencing, and RNA analysis. The mission of the Lexogen team is to empower their customers with innovative top quality RNA analysis solutions and support, in order to improve health and well-being for everyone and our planet. Lexogen is the leader in 3’ RNA sequencing, a technology proven for its efficiency, its robustness, and its sensitivity.